Update of diagnosis and treatment of heart failure of chagasic etiology

被引:0
作者
Gimenez, Luisa J.
Mitelman, Jorge E.
Pineiro, Daniel J.
Nunez Burgos, Federico
Sabra, Ahmad
Feitosa, Gilson
de Oliveira Junior, Wilson
Fernandez Chamorro, Felipe Nery Gervacio
Blandon Calderon, Roberto
Aguirre, Fernando
Rosas Andrade, Fernando
Uriona Villarroel, Juan
Bulla Fernandez, Daniel
Linarez Ochoa, Nery E.
Luis Barisani, Jose
Romero, Analia
Gonzalez, Marcos
Melnikov, Valery
Macedo Linares, Ana Maria
Buitrago Rodriguez, Maria Fernanda
Gutierrez Perucho, Ernesto
Justiniano Encina, Juan
Gutierrez Sotelo, Oswaldo
Bonilla, Rafael
Guzman Melgar, Ismael
Almonte, Claudia
Echeverria Frias, Carlos
Mendoza, Ivan
Newton-Sanchez, Oscar
Dones Figueroa, Wistremundo
Simeone, Andrea
机构
关键词
Chagas disease; Heart failure; Chagas cardiomyopathy; Latin America; Trypanosoma cruzi; Hospitalization; Mortality; RISK STRATIFICATION; RANDOMIZED-TRIAL; MORTALITY; DISEASE; CARDIOMYOPATHY; ENALAPRIL; BENZNIDAZOLE; EFFICACY; SAFETY; DEATH;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chagas disease is a important public health problem throughout America, extended worldwide, both by external and internal migrations, with heart failure being one of the most serious complications of chagasic cardiomyopathy, with severe repercussions on both the individual and his family, not only with involvement in the quality of life, but with a significant number of cardiological complications such as severe and complex arrhythmias, strokes and even sudden death. As well, It is expensive in medical treatments, hospitalizations, use of electronic devices; transplants, etc. A group of Latin American experts have made an update based on their experience accompanied by an important bibliographic review in order to update the usual clinical and complementary diagnoses and of high complexity, as well as the treatments currently available for this complication, and they must be adapted to the availability of health care centers.
引用
收藏
页码:96 / 110
页数:15
相关论文
共 50 条
[11]   OVERVIEW OF RANDOMIZED TRIALS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON MORTALITY AND MORBIDITY IN PATIENTS WITH HEART-FAILURE [J].
GARG, R ;
YUSUF, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (18) :1450-1456
[12]  
Gascón J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1157/13100280
[13]   Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events - A meta-analysis [J].
Gehi, AK ;
Stein, RH ;
Metz, LD ;
Gomes, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :75-82
[14]   Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis [J].
Ghaffarpasand, Eiman ;
Tehrani, Maneli D. ;
Marszalek, Jolanta ;
Chi, Gerald .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (03) :332-338
[15]  
Gimenez L, 2003, REV ARGENT CARDIOL, V71, P109
[16]  
Gimenez L, 2006, REBLAMPA, V19, P155
[17]  
Gimenez LJ, 2016, REV FED ARGENT CARDI, V45, P56
[18]  
Gutiérrez-Sotelo Oswaldo, 2007, Acta méd. costarric, V49, P97
[19]   Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy The Past, Present, and Future [J].
Halliday, Brian P. ;
Cleland, John G. F. ;
Goldberger, Jeffrey J. ;
Prasad, Sanjay K. .
CIRCULATION, 2017, 136 (02) :215-231
[20]   Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials [J].
Heidenreich, PA ;
Lee, TT ;
Massie, BM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) :27-34